Arbutus Biopharma
2 followers
‌
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).
Industries
Headquarters
Employees
Links
Org chart
Michael McElhaugh
Collapse
David C. Hastings
Chief Financial Officer
Elizabeth Howard
EVP, General Counsel & Chief Compliance Officer
Michael J. Sofia Phd
Chief Scientific Officer
Karen Sims
Chief Medical Officer
Catherine Coffey Ross
Vice President Commercial Development
Michael Child
Vice President Clinical Operations
Shannon Briscoe
Vice President Human Resources
Ganapati Reddy Pamulapati
Senior Vice President, Pharmaceutical Development And Manufacturing
Similar companies
Pendulum
4 followers
Stemline Therapeutics
3 followers
Sutro Biopharma
2 followers
Inari
1 follower
Fortis Life Sciences
1 follower
Capsida Biotherapeutics
1 follower
Zageno
1 follower
Matica Biotechnology
1 follower
Lineage Cell Therapeutics
1 follower
Eikon Therapeutics
1 follower
Thermo Fisher Scientific
149 followers
Discover companies